Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Tue, March 21, 2023
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
Derek Archila Initiated (VTYX) at Buy and Held Target at $77 on, Mar 21st, 2023
Derek Archila of Wells Fargo, Initiated "Ventyx Biosciences, Inc." (VTYX) at Buy and Held Target at $77 on, Mar 21st, 2023.
Derek has made no other calls on VTYX in the last 4 months.
There are 4 other peers that have a rating on VTYX. Out of the 4 peers that are also analyzing VTYX, 0 agree with Derek's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Derek
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Monday, March 20th, 2023
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, January 31st, 2023
- Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $60 on, Friday, January 27th, 2023
- Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $50 on, Monday, December 19th, 2022
